FDA Confirms NMN Dietary Supplement Status in 2025: A Win for Consumers and the Industry
The FDA NMN dietary supplement status 2025 update marks a turning point for longevity supplements. Nicotinamide mononucleotide (NMN) has been one of the most researched and talked-about molecules in this space. But in 2022, the FDA suddenly banned NMN from being sold as a dietary supplement in the United States, citing pharmaceutical drug exclusivity rules. […]